April 1st 2024
Acceptance of the IND application would initiate a first-in-human phase 1 dose expansion and escalation trial of CTIM-76 in patients with testicular and gynecologic cancers.
Medical Crossfire®: Expert Exchanges to Maximize Clinical Outcomes for Patients with CRPC Through Evidence-Based Personalized Therapy
View More
How the Experts Treat NMIBC During a BCG Shortage—Integrating Recent Approvals and Investigational Therapies
View More
Staying Abreast of the Prostate Cancer Treatment Paradigm From Risk Stratification to Adaptive Sequencing Strategies
View More
Everything You Need to Know About PARP Inhibitor Combinations in Prostate Cancer Care: Why? For Whom? And When?
View More
Clinical Case Vignette Series: Integrating Recent Data into Practice to Improve Outcomes in Advanced Prostate Cancer
View More
Medical Crossfire®: How Will Emerging Data Inform Treatment Planning for Patients With Prostate Cancer in the Community?
View More
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
Challenging case: A young woman presenting with rapid weight gain
July 25th 2018An 18-year-old previously healthy collegiate athlete presented to the emergency room with a rapid weight gain of 20 pounds during the previous 2 months. She complained of significant fatigue and irregular menstrual periods.
Bladder Ca assay shows high sensitivity, specificity
July 24th 2018Studies finding that fatty acid binding protein 5 is preferentially overexpressed in high-risk prostate cancer and that a ketogenic diet significantly inhibited tumor growth in a mouse model of clear cell RCC were among other AUA 2018 take-home messages in basic science (malignant).
Minimally invasive surgery: PN can be used for complex tumors
July 13th 2018Noteworthy minimally invasive surgery research from AUA 2018 also included topics such as robot-assisted versus open radical cystectomy as well as minimally invasive retroperitoneal lymph node dissection in men with testis cancer.
mpMRI Bx protocol may reduce repeat biopsies, but at what cost?
July 12th 2018"Despite the potential benefits (fewer biopsies, less cost), the proposed approach to cancer detection and biopsy-that can miss 16%-40% of existing csPCa-may be difficult to justify for all patients," writes Badar M. Mian, MD.
Imaging: Artificial intelligence may improve interpretation of MRI
July 12th 2018Contrast-enhanced ultrasound for detecting renal cell carcinoma recurrence following ablation and new protocols for low-dose computed tomography in stone patients were among the other research highlights in imaging at the AUA annual meeting.
Kidney Ca: Robotic partial, radical nephrectomy on the rise
July 11th 2018Active surveillance in selected patients with localized renal masses 4 cm to 7 cm and a patient-derived xenograft system for predicting response to targeted and immune therapies in patients with metastatic RCC were among other noteworthy kidney cancer studies presented at AUA 2018.
Bladder Ca: Immunotherapy shows promise as neoadjuvant treatment before RC
July 11th 2018Other bladder cancer take-home messages covered topics such as artificial intelligence and deep learning for staging of T1 disease as well as a wearable fitness tracker for collecting data on physical activity after radical cystectomy.
AUA 2018 take-homes highlight guidelines, opioids, robotics
July 11th 2018Three new clinical guidelines, potentially practice-changing advances in robotics and artificial intelligence, and research on hot-button public health issues such as opioid abuse were among many highlights of the AUA annual meeting in San Francisco.
How fusion Bx affects prostate Ca management
July 5th 2018Findings from a retrospective analysis of data collected at the National Institutes of Health provide insight on how multiparametric MRI/transrectal ultrasound-fusion biopsy (“fusion biopsy”) may be affecting management patterns and outcomes for men with prostate cancer.
AUA ’18: Experts pick this year’s key research
May 8th 2018To help you sift the enormous scientific program and prioritize your schedule at the AUA annual meeting, the editors have called upon Urology Times’ editorial advisory board to identify the key research across multiple areas of the specialty.